Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Yokoi: Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant.... (0.12 sec) 

Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant …

- nih.gov - Free from Publisher
M Yokoi, SI Yamagishi, M Takeuchi, K Ohgami … - British Journal of Ophthalmology, 2005 - bjo.bmj.com
Background/aims: Advanced glycation end product (AGE) induces vascular
endothelial growth factor (VEGF) expression in cell culture and animal models,
being considered to be involved in development of diabetic retinopathy; ...
Cited by 40 - Related articles - All 8 versions

Pigment epithelium-derived factor (PEDF) prevents diabetes-or advanced glycation end …


S Yamagishi, T Matsui, K Nakamura, M … - Microvascular Research, 2006 - Elsevier
Pigment epithelium-derived factor (PEDF) is the most potent inhibitor of
angiogenesis in the mammalian eye, suggesting that PEDF may protect against
proliferative diabetic retinopathy. However, a role for PEDF in early ...
Cited by 24 - Related articles - All 3 versions

Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal …

- jbc.org
S Yamagishi, K Nakamura, T Matsui, Y Inagaki … - Journal of Biological Chemistry, 2006 - ASBMB
Pigment epithelium-derived factor (PEDF) is the most potent inhibitor of
angiogenesis, suggesting that loss of PEDF contributes to proliferative diabetic
retinopathy. However, the role of PEDF against retinal vascular ...
Cited by 49 - Related articles - BL Direct - All 7 versions

Positive correlation between vitreous levels of advanced glycation end products and vascular …


M Yokoi, S Yamagishi, M Takeuchi, T Matsui … - British Medical Journal, 2007 - bjo.bmj.com
We investigated whether vitreous levels of advanced glycation end products
(AGEs) were positively correlated with vascular endothelial growth factor (VEGF)
in patients with diabetic retinopathy patients sufficiently treated with ...
Cited by 7 - Related articles - All 5 versions

Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of …

- iovs.org
Y Kaji, T Usui, S Ishida, K Yamashiro, TCB … - Investigative ophthalmology & visual science, 2007 - ARVO
1 From the Department of Ophthalmology, University of Tsukuba, Institute of
Clinical Medicine, Ibaraki, Japan; the 2 Department of Ophthalmology, Graduate
School of Medicine, University of Tokyo, Tokyo, Japan; the 3 Department of ...
Cited by 26 - Related articles - BL Direct - All 4 versions

[PDF] Beraprost sodium, a prostaglandin I2 analogue, protects against advanced gycation end …


S Yamagishi, S Amano, Y Inagaki, T Okamoto, … - Molecular Medicine, 2002 - molmed.org
Molecular Medicine 8(9): 546–550, 2002 © 2002 North Shore-LIJ Research
Institute ... Beraprost Sodium, a Prostaglandin I2 Analogue, Protects Against
... Advanced Glycation End Products-induced Injury in Cultured
Cited by 26 - Related articles - View as HTML - BL Direct - All 7 versions

The RAGE axis in early diabetic retinopathy

- iovs.org
GR Barile, SI Pachydaki, SR Tari, SE Lee, … - Investigative ophthalmology & visual science, 2005 - ARVO
RESULTS. Early inner retinal neuronal dysfunction, manifested by prolonged
latencies of the oscillatory potentials and b-wave, was detected in
hyperglycemic mice. HGHL mice exhibited accelerated development of ...
Cited by 56 - Related articles - BL Direct - All 4 versions

Diabetic vascular complications: pathophysiology, biochemical basis and potential …


S Yamagishi, T Imaizumi - Current pharmaceutical design, 2005 - ingentaconnect.com
Abstract: Diabetic vascular complication is a leading cause of end-stage renal
failure, acquired blindness, a variety of neuropathies and accelerated
atherosclerosis, which could account for disabilities and high mortality ...
Cited by 123 - Related articles - All 3 versions

Advanced glycation end products-induced apoptosis and overexpression of vascular …


S Yamagishi, S Amano, Y Inagaki, T Okamoto, … - Biochemical and Biophysical Research …, 2002 - Elsevier
The influence of advanced glycation end products (AGEs) on apoptotic cell death
and vascular endothelial growth factor (VEGF) gene expression in cultured bovine
retinal pericytes was investigated. When pericytes were incubated with ...
Cited by 98 - Related articles - BL Direct - All 6 versions

Serum levels of glucose-derived advanced glycation end products are associated with the …


K Koga, S Yamagishi, T Okamoto, Y Inagaki, … - International journal of clinical pharmacology research, 2002 - cat.inist.fr
Reducing sugars can react nonenzymatically with the amino groups of proteins to
form Amadori products and subsequently cross-linked, heterogeneous fluorescent
derivatives called advanced glycation end products(AGE). AGE can arise in ...
Cited by 16 - Related articles - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google